Our major goal is to elucidate the mechanisms responsible for the modulation of cell growth and other cell functions by TNF. In view of the many documented cooperative actions of TNF, IFNs and other cytokines on various cell functions, we shall pay special attention to the study of the interactions between TNF, the IFNs (both IFN-alpha/beta and IFN-lambda), interleukin (IL)-1 and IL-6. Most biological actions of TNF and cytokines can be attributed to their ability to modulate gene expression in target cells. In the first part of the proposed studies we shall seek a better understanding of the molecular mechanisms of gene regulation by TNF, using the ability of TNF to induce IL-6 synthesis in human fibroblasts as our main model system. The goals are to gain a more complete understanding of the cis-acting elements and trans-activating factors as well as of the major signal transduction pathways responsible for IL-6 induction by TNF. In the second part of the proposed studies we shall use a set of recently cloned DNAs complementary to mRNAs whose levels are enhanced by TNF treatment in human diploid fibroblasts. The induction characteristics of mRNAs corresponding to these cDNAs will be determined (e.g., kinetics of induction by TNF, tissue specificity of induction by TNF, inducibility by IFN-alpha/beta, IFN-lambda and other cytokines, etc.). We shall also analyze the role of recently identified transcription factors, including interferon regulatory factor-1 and -2 (IRF-1 and 2), in TNF-regulated gene expression and in the synergistic actions of TNF and IFNs on gene expression.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Unknown (R35)
Project #
1R35CA049731-01A2
Application #
3479727
Study Section
Special Emphasis Panel (SRC (88))
Project Start
1991-04-01
Project End
1998-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Alpert, D; Vilcek, J (2000) Inhibition of IkappaB kinase activity by sodium salicylate in vitro does not reflect its inhibitory mechanism in intact cells. J Biol Chem 275:10925-9
Goodman, A R; Levy, D E; Reis, L F et al. (2000) Differential regulation of TSG-14 expression in murine fibroblasts and peritoneal macrophages. J Leukoc Biol 67:387-95
Poppers, D M; Schwenger, P; Vilcek, J (2000) Persistent tumor necrosis factor signaling in normal human fibroblasts prevents the complete resynthesis of I kappa B-alpha. J Biol Chem 275:29587-93
Gerecitano, J; Perle, M A; Vilcek, J (1999) Transcriptional basis for the differences in inducible nitric oxide synthase (iNOS) expression between nonmetastatic and metastatic murine melanoma cell lines. J Interferon Cytokine Res 19:393-405
Schwenger, P; Alpert, D; Skolnik, E Y et al. (1999) Cell-type-specific activation of c-Jun N-terminal kinase by salicylates. J Cell Physiol 179:109-14
Alpert, D; Schwenger, P; Han, J et al. (1999) Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation. J Biol Chem 274:22176-83
Wisniewski, H G; Vilcek, J (1997) TSG-6: an IL-1/TNF-inducible protein with anti-inflammatory activity. Cytokine Growth Factor Rev 8:143-56
Schwenger, P; Bellosta, P; Vietor, I et al. (1997) Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci U S A 94:2869-73
Wisniewski, H G; Hua, J C; Poppers, D M et al. (1996) TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong anti-inflammatory effect in vivo. J Immunol 156:1609-15
Wisniewski, H G; Naime, D; Hua, J C et al. (1996) TSG-6, a glycoprotein associated with arthritis, and its ligand hyaluronan exert opposite effects in a murine model of inflammation. Pflugers Arch 431:R225-6

Showing the most recent 10 out of 40 publications